» Articles » PMID: 8193062

Specificity of the Calgary Depression Scale for Schizophrenics

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 1994 Feb 1
PMID 8193062
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

This study sought to determine the specificity of the Calgary Depression Scale (CDS), a depression rating scale for schizophrenics. The specificity is the degree to which the scale assesses depression rather than negative or extrapyramidal symptoms. Subjects were 100 outpatients (OP) and 50 inpatients (IP) meeting DSM-III-R criteria for schizophrenia. Negative symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS); extrapyramidal symptoms were assessed with the Simpson Angus Scale (SA) and depression with the CDS. Results were that the CDS showed no correlation with SA, but weak (0.33) statistically significant correlations with the PANSS negative symptom score in inpatients but not outpatients. Confirmatory factor analysis using Lisrel 6.0 showed that the model hypothesizing specificity of depression, negative symptoms and extrapyramidal symptoms, was significant, with a goodness of fit index of 0.89 and a root mean square residual of 0.07. It is concluded that the CDS achieves a useful degree of separation between measures of depression, negative and extrapyramidal symptoms in subjects with schizophrenia, when combined with the other measures used in this study.

Citing Articles

Network analysis of clinical features in patients with treatment-resistant schizophrenia.

Li W, Zhao J, Hu N, Zhang W Front Psychiatry. 2025; 16:1537418.

PMID: 39980982 PMC: 11839625. DOI: 10.3389/fpsyt.2025.1537418.


Differences in metabolic biomarkers in people with schizophrenia who are of Mexican descent compared to non-Hispanic whites.

Kwak P, Ibarra C, Hernandez A, Carrasco J, Sears D, Jeste D Psychiatry Res. 2024; 334:115788.

PMID: 38401486 PMC: 11249025. DOI: 10.1016/j.psychres.2024.115788.


Late onset psychosis treatment with adjunctive medicines.

Boksha I, Savushkina O, Sheshenin V, Tereshkina E, Prokhorova T, Pochueva V Front Psychiatry. 2024; 14:1319891.

PMID: 38188053 PMC: 10768183. DOI: 10.3389/fpsyt.2023.1319891.


The mediating role of negative symptoms in "secondary factors" determining social functioning in chronic schizophrenia.

Hu N, Li W, Deng H, Song J, Yang H, Chai J Front Psychiatry. 2023; 14:1196760.

PMID: 37649558 PMC: 10464835. DOI: 10.3389/fpsyt.2023.1196760.


Immunological routine laboratory parameters at admission influence the improvement of positive symptoms in schizophrenia patients after pharmacological treatment.

Skalniak A, Krzysciak W, Smierciak N, Szwajca M, Donicz P, Kozicz T Front Psychiatry. 2023; 14:1082135.

PMID: 37032951 PMC: 10073498. DOI: 10.3389/fpsyt.2023.1082135.